Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197872 · ClinicalTrials.gov registry record
Clinical Use of Parental Support To Detect Single Gene Mutations
A clinical trial, sponsored by Natera.
- Completed
- Registry status
- 240
- Enrollment target
NCT01197872: Completed study, sponsored by Natera.
NCT01197872 is a clinical trial that has completed, run by Natera. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01197872 has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
Gene Security Network has developed a novel technology called Parental Support (PS) which is used for Preimplantation Genetic Screening/Diagnosis (PGS/D) during in vitro fertilization (IVF). This technology allows IVF physicians to identify embryos, prior to transfer to the uterus, which have the best chance of developing into healthy children.
Primary Outcome
Confirmation of PGS test results through prenatal diagnosis
Interventions
- OTHER Preimplantation Genetic Diagnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-06 |
What the finished NCT01197872 record still lists
NCT01197872 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Preimplantation Genetic Diagnosis is the first listed.
NCT01197872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01197872 about?
NCT01197872 is a clinical study titled "Clinical Use of Parental Support To Detect Single Gene Mutations". Gene Security Network has developed a novel technology called Parental Support (PS) which is used for Preimplantation Genetic Screening/Diagnosis (PGS/D) during in vitro fertilization (IVF). This technology allows IVF physicians to identify embryos, prior to transfer to the uterus, which have the be...
What is the current status of trial NCT01197872?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2010-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01197872?
The interventions under investigation include: Preimplantation Genetic Diagnosis (OTHER).
Who is sponsoring clinical trial NCT01197872?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia